1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Erasca, Inc.
  6. News
  7. Summary
    ERAS   US29479A1088

ERASCA, INC.

(ERAS)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about ERASCA, INC.
05/25Erasca Strengthens Clinical and Commercial Leadership with Three Key Appointments
AQ
05/25Erasca, Inc. Announces Key Appointments
CI
05/12Erasca Narrows Q1 Loss, Misses Street Estimates
MT
05/12Earnings Flash (ERAS) ERASCA Reports Q1 Loss $-0.31
MT
05/12Erasca Reports First Quarter 2022 Financial Results and Business Updates
GL
05/12Erasca, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
05/03Erasca to Present at the Bank of America Securities 2022 Healthcare Conference
AQ
04/27Erasca Appoints Jean Liu to its Board of Directors
AQ
04/27Erasca Appoints Jean Liu to its Board of Directors
CI
04/12Erasca Says Data Support Clinical Development of Certain Programs
MT
04/12Erasca Presents Compelling Preclinical Data Supporting Clinical Development of Potentia..
AQ
04/06Erasca To Host Investor Event with Leading KOL Dr. Scott Kopetz on Therapeutic Opportun..
AQ
03/24ERASCA : Reports Fourth Quarter 2021 Financial Results and Business Updates - Form 8-K
PU
03/24Erasca, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2021
CI
03/24Erasca, Inc. Expects Initial Phase 1b Monotherapy Data in Second Half of 2022
CI
More most relevant news
All news about ERASCA, INC.
05/25Erasca Strengthens Clinical and Commercial Leadership with Three Key Appointments
AQ
05/25Erasca, Inc. Announces Key Appointments
CI
05/12Erasca Narrows Q1 Loss, Misses Street Estimates
MT
05/12ERASCA, INC. Management's Discussion and Analysis of Financial Condition and Results o..
AQ
05/12Earnings Flash (ERAS) ERASCA Reports Q1 Loss $-0.31
MT
05/12Erasca Reports First Quarter 2022 Financial Results and Business Updates
GL
05/12Erasca, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
05/03Erasca to Present at the Bank of America Securities 2022 Healthcare Conference
AQ
04/27ERASCA, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
04/27Erasca Appoints Jean Liu to its Board of Directors
AQ
More news
News in other languages on ERASCA, INC.
05/25Erasca, Inc. annonce des nominations clés
05/12Erasca réduit sa perte au 1er trimestre et ne respecte pas les estimations de la Bourse
05/12Erasca, Inc. annonce ses résultats pour le premier trimestre se terminant le 31 mars 20..
04/27Erasca nomme Jean Liu à son conseil d'administration
04/12Erasca affirme que les données soutiennent le développement clinique de certains progra..
03/24Erasca, Inc. annonce ses résultats pour le quatrième trimestre clos le 31 décembre 2021
03/24Erasca, Inc. attend les premières données de phase 1b en monothérapie au second semestr..
03/24Erasca, Inc. annonce ses résultats pour le quatrième trimestre clos le 31 décembre 2021
01/18Erasca, Inc. annonce des changements de direction
2021Erasca sera intégré à l'indice Nasdaq des biotechnologies
More news
Analyst Recommendations on ERASCA, INC.
01/03Guggenheim Adjusts Price Target for Erasca to $20 From $25, Maintains Buy Rating
MT
2021ERASCA : Evercore ISI Starts Erasca at Outperform With $45 Price Target
MT
2021ERASCA : Guggenheim Starts Erasca at Buy With $25 Price Target
MT
2021ERASCA : BofA Securities Starts Erasca at Buy With $28 Price Target
MT
2021ERASCA : JPMorgan Starts Erasca at Overweight With $28 Price Target
MT
More recommendations
Press releases
05/25Erasca Strengthens Clinical and Commercial Leadership with Three Key Appointments
AQ
05/12ERASCA, INC. Management's Discussion and Analysis of Financial Condition and Results o..
AQ
05/12Erasca Reports First Quarter 2022 Financial Results and Business Updates
GL
05/03Erasca to Present at the Bank of America Securities 2022 Healthcare Conference
AQ
04/27ERASCA, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
More press releases
Upcoming event on ERASCA, INC.